MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong start to 2025, with first-quarter revenue reaching $18.5 million, a 12% increase compared to the same period last year and a 5% sequential growth over Q4 2024. The company credited rising demand for its OviTex® and OviTex PRS Reinforced Tissue Matrix products, which saw year-over-year revenue growth of approximately 15% and 2%, respectively.
“We are pleased with the strong performance in the first quarter of 2025 following the realignment and optimization of our sales organization,” said Antony Koblish, President and CEO of TELA Bio. “The complementary dynamic between our Territory Managers and Account Specialists enabled new account wins and greater market penetration across our product portfolio. We are focused on carrying this momentum throughout 2025 as we aim to drive higher revenue growth and increased operating leverage and continue to drive towards profitability.”
During Q1, TELA Bio launched larger-sized OviTex PRS, a product designed to simplify complex plastic and reconstructive surgeries by reducing the need for multiple smaller pieces. The launch is expected to support the company’s goal of increasing its footprint in plastic and reconstructive surgery markets.
Operating expenses for the quarter were $22.9 million, slightly lower than the previous year’s $23.7 million, reflecting efficiency improvements initiated in 2024. However, the company recorded a net loss of $11.3 million for Q1, attributed in part to the absence of asset sale gains seen in the prior period. TELA Bio ended the quarter with $42.8 million in cash and cash equivalents.
Looking ahead, the company reaffirmed its full-year 2025 revenue guidance of $85.0 million to $88.0 million, representing a 23% to 27% increase year-over-year. Additionally, operating expenses for the year are expected to remain flat compared to 2024.
By leveraging its expanded product portfolio and optimized sales strategy, TELA Bio aims to build on its Q1 momentum and deliver sustainable growth for the remainder of the year.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.